Fig. 8From: ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacyCorrelation of ESRRG and PKM2 in ESCC. A IHC analysis for ESRRG and PKM2 expression in clinical HCC samples. Scale bars = 100 μm. B Correlation between ESRRG expression and PKM2 expression (Chi-squared test). C Prognostic value of combining ESRRG and PKM2 levels was analyzed by Kaplan–Meier analysis in 94 ESCC samples. D Model illustrating tumor suppression mechanism regulated by ESRRG in ESCC progressionBack to article page